NICE gets ready to assess new dementia treatments

20 November 2023 - NICE’s methods and processes for evaluating new treatments for use in the NHS are appropriate for the ...

Read more →

Dismay as UK ‘drags its heels’ on AZ’s COVID antibody Evusheld

12 August 2022 - Half a million people in the UK with conditions like blood cancer that prevents them being ...

Read more →

UK lags behind EU in authorising new medicines after Brexit

14 July 2022 - Experts attribute shortfall to small size of British market now it is regulated separately and complexity of ...

Read more →

Response to engagement on proposals for the Innovative Medicines Fund

7 June 2022 - NHS England and NICE asked for comments on our proposals for the Innovative Medicines Fund.  ...

Read more →

Patients to have earlier access to cutting edge treatments on NHS

7 June 2022 - The most promising medicines will be fast-tracked to NHS patients through Innovative Medicines Fund ...

Read more →

Patients to receive new cancer drugs faster under Brexit rules shake-up

23 January 2022 - Seven medicines already approved as changes cut as much as a month off approval times. ...

Read more →

UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile

19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...

Read more →

Brexit means coronavirus vaccine will be slower to reach the UK

15 March 2020 - And it will cost more here because of the UK pulling out of the European Medicines Agency ...

Read more →

Cancer patients facing delays in getting ‘innovative’ drugs

29 January 2020 - A new analysis report has found that most innovative cancer drugs face delays in reaching patients. ...

Read more →

Game-changing cancer drugs which can attack all tumours will be fast-tracked by NHS

19 June 2019 - Game-changing cancer drugs which can attack all types of tumour will be fast-tracked by the NHS, ...

Read more →

The shadow of Brexit on speed of access

20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union.  ...

Read more →

One in four cancer patients wait two months for treatment, as NHS performance hits record low

14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...

Read more →

Choosing a time horizon in cost and cost-effectiveness analyses

21 February 2019 - When designing a comparative outcomes or a cost-effectiveness analysis, the time horizon defining the duration of time ...

Read more →

NHS to save £1 billion on its medicines bill in 2019

5  December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...

Read more →

Flexibility on cancer drugs approval will foster innovation

4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...

Read more →